Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Checkpoint Checkmate: Adverse Event Management for Checkpoint Inhibitors
• FDA Approves Gamifant, the First Drug to Treat Hemophagocytic Lymphohistiocytosis
• FDA Approves Hyrimoz, Third Humira Biosimilar
• FDA Expands Approval of Rituxan for Two Rare Forms of Vasculitis
• FDA Allows for Expanded Marketing of 23andMe to Include Medication Metabolism
• Pfizer Initiates Phase 3 Trial of Tofacitinib for Ankylosing Spondylitis
• Social Media as a Creative/Disruptive Force in Rheumatology (or Why I Now Tweet) Leonard H. Calabrese, DO
• AWIR 2nd Annual Immunology Bootcamp Part 1: TNF and IL-6 Biology and Inhibitors
• FDA Approves Dsuvia for Acute Pain Management
• FDA Warns 465 Websites Selling Unapproved Opioids, Drugs for Cancer, HIV
• Crowdsourcing Health Care: Is the Customer Always Right?
• ACR Announces Draft Guidelines for Reproductive Health Management
• Draft Criteria for IgG4-related Disease Diagnosis Emphasize Multi-factorial Presentation
• Draft Criteria for Large-vessel Vasculitis Support Key Role for Imaging
• Trump Proposes Allowing Medicare to Base Drug Costs on Prices Abroad
• Adherence, Persistence Low in Veterans With RA Who Escalate to Triple Therapy
• Back Pain in Teens Tied to Smoking, Drinking Alcohol, Anxiety, Depression
• Dual VA, Medicare Enrollment Linked to Overlapping Opioid, Benzodiazepine Prescriptions
• Improved Quadricep Strength Linked to Better Function in Women With OA
• No Increased Adverse Events, Health Care Use in Treat-to-target Strategies for RA
• On-demand Sildenafil Not Superior to Placebo for Raynaud’s Syndrome
• Patient Education Does Not Improve Pain Outcomes
• Physical Therapies Underused Following Total Knee Replacement
• Poor JIA Prognosis More Likely Among Maori, Pacific Island Children
• PsA Disease Activity in Women Highest at 6 Months Postpartum
• Rheumatology Fellows Unsure How to Engage in Health Policy, Advocacy
• Text Message Reminders Improve Methotrexate Adherence in RA
• US Leads Developed Nations in Drug Overdose Deaths
• All Gains in Infliximab Biosimilar Use Have Gone to Inflectra
• Biologic Tapering Successful, Cost-effective in Low-activity RA
• Children With JIA Have Higher Rate of Adverse Childhood Experiences
• Comorbidity in Patients With RA Affects Disease Activity
• 'Culturally Competent' Online Resource Raises Lupus Awareness in At-risk Populations
• Experts Debate Hydroxychloroquine Dosing Guidelines in Lupus
• Half of Patients With RA Do Not Modify Therapies to Meet Treat-to-target Guidelines
• Hard-to-treat Patients With Sclerosis Respond to Stem Cell Transplantation
• IgG Antiphospholipid Antibodies Linked to Heart Attack
• Opioid Use Common Before Total Joint Replacement Surgery
• Recurrent Lupus Nephritis Less Frequent After Kidney Transplant
• Vascular Ultrasound Highly Sensitive, Specific for Large-vessel GCA Diagnosis
• Hematopoietic Stem Cell Transplantation for Scleroderma Durable After 6 to 11 Years
• No Correlation Between Race, Poverty and Risk for TKR Failure
• B-cell Receptor Clones Predict High Risk for Rheumatoid Arthritis
• Failure to Achieve Serum Urate Target Increases Death Risk in Gout
• Augmenting the Risk: Breast Implants Linked to Rheumatic, Autoimmune Diseases
• CIRT: Methotrexate Fails to Prevent Atherosclerotic Events
• CMS Proposes Revisions to Improve Medicaid, CHIP Managed Care
• Few Rheumatic Adverse Events From Immune Checkpoint Inhibitors Require Discontinuation
• Legacy Prescribing Appears Common in Primary Care
• Psychiatric Disorders, CVD, IBD More Prevalent in Psoriasis With PsA